Result of the chromosomal anomaly

Raimondi Sc, Hoffbrand Av, Fay Wright(Northern Westchester Hospital), Williams Dl, Roberts Wm, Enrica Privitera(St. Jude Children's Research Hospital), Anupam Mehta, Mallika Sekhar(Royal Free London NHS Foundation Trust), D Samson, F G Behm(St. Jude Children's Research Hospital), Devaraj Pe, Crist Wm, TA Butler, Jolly Kw, Letizia Foroni(Centre for Inflammation Research), Prentice Hg, Toshiya Inaba(Hiroshima University)

Unknown

January 1, 1999

Cited by 0

Related Papers

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

|Blood|2007|782

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

|Blood|2006|746

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

|The Lancet|1991|387

The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13.

|Proceedings of the National Academy of Sciences|1991|371

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

|Blood|1996|363